There is a growing body of scientific evidence contributing to the development of clinical transplantation programs in patients with Huntington's disease. Phase I clinical trials have already commenced in France and North America and are starting in the near future in Sweden and the UK. Protocols for patient selection, surgical implantation, and pre- and postoperative follow-up are well defined. However, considerable variability exists with respect to the harvesting, preparation, and timing of implantation of the donor material. In this article we review the scientific evidence on which a rational protocol for donor tissue preparation and delivery may be based. Strategies aimed at minimizing the variability of tissue preparation should reduce the variability of functional outcome of striatal transplantation observed in animal models of Huntington's disease.
AlexanderG. E.; CrutcherM. D.Functional architecture of basal ganglia circuits: Neural substrates of parallel processing.Trends Neurosci.13: 266–271; 1990.
2.
BayerS. A.Neurogenesis in the rat neostriatum.Int. J. Dev. Neurosci.2: 163–175; 1984.
3.
BayerS. A.Development of the lateral and medial limbic cortices in the rat in relation to cortical phylogeny.Exp. Neurol.107: 118–131; 1990.
4.
BealM. F.; KowallN. W.; SwartzK. J.; FerranteR. J.; MartinJ. B.Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions.Synapse3: 38–47; 1989.
5.
BelkadiA. M.; GenyC.; NaimiS.; JenyR.; PeschanskiM.; RicheD.Maturation of fetal human neural xenografts in the adult rat brain.Exp. Neurol.144: 369–380; 1997.
6.
BernardV.; LegayC.; MassoulieJ.; BlochB.Anatomical analysis of the neurons expressing the acetylcholinesterase gene in the rat brain, with special reference to the striatum.Neuroscience64: 995–1005; 1995.
7.
BjörklundA.; SteneviU.Intracerebral neural implants: Neuronal replacement and reconstruction of damaged circuitries.Annu. Rev. Neurosci.7: 279–308; 1984.
8.
BjörklundA.; CampbellK.; SirinathsinghjiD. J. S.; FlickerR. A.; DunnettS. B.Functional capacity of striatal transplants in the rat Huntington model. In: DunnettS. B.; BjörklundA., eds. Functional neural transplantation.New York: Raven Press;1994: 157–195.
9.
BolamP. J.Synapses of identified neurons in the neostriatum. In: EveredD.; O'ConnorM., eds. Functions of the basal ganglia: Chiba Foundation Symposium.London: Pitman;1984: 30–47.
10.
BrownellA. L.; HantrayeP.; WullnerU.; HambergL.; ShoupT.; ElmalehD. R.; FrimD. M.; MadrasB. K.; BrownellG. L.; RosenB. R.PET- and MRI-based assessment of glucose utilization, dopamine receptor binding, and hemodynamic changes after lesions to the caudate-putamen in primates.Exp. Neurol.125: 41–51; 1994.
11.
BrundinP.; FlickerR. A.; NakaoN.Paucity of P-zones in striatal grafts prohibit commencement of clinical trials in Huntington's disease.Neuroscience71: 895–897; 1996.
12.
ButcherL.; WolfN.Histochemical distribution of acetylcholinesterase in the central nervous system: Clues to the localisation of cholinergic neurons. In: BjörklundA.; HokfeltT.; KuharM., eds. Handbook of chemical neuroanatomy, vol. 3.Amsterdam: Elsevier;1984: 1–50.
13.
DeaconT. W.; PakzabanP.; IsacsonO.The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: Neural transplantation and developmental evidence.Brain Res.668: 211–219; 1994.
14.
De CarlosJ. A.; Lopez-MascaraqueL.; ValverdeF.Dynamics of cell migration from the lateral ganglionic eminence in the rat.J. Neurosci.16: 6146–6156; 1996.
DeckelA. W.; MoranT. H.; RobinsonR. G.Behavioral recovery following kainic acid lesions and fetal implants of the striatum occurs independent of dopaminergic mechanisms.Brain Res.363: 383–385; 1986.
17.
DeckelA. W.; MoranT. H.; RobinsonR. G.Receptor characteristics and recovery of function following kainic acid lesions and fetal transplants of the striatum. I. Cholinergic systems.Brain Res.474: 27–38; 1988.
18.
DeckelA. W.; MoranT. H.; RobinsonR. G.Receptor characteristics and recovery of function following kainic acid lesions and fetal transplants of the striatum. II. Dopaminergic systems.Brain Res.474: 39–47; 1988.
19.
DifigliaM.; SchiffL.; DeckelW.Neuronal organization of fetal striatal grafts in kainate and sham lesioned rat caudate nucleus: Light and electron microsopic observations.J. Neurosci.8: 1112–1130; 1988.
20.
DunnettS. B.Functional repair of striatal systems by neural transplants: Evidence for circuit reconstruction.Behav. Brain Res.66: 133–142; 1995.
21.
DunnettS. B.; BjörklundA.Mechanisms of function of neural grafts in the injured brain. In: DunnettS. B.; BjörklundA., eds. Functional neural transplantation.New York: Raven Press;1994: 531–567.
22.
DunnettS. B.; IsacsonO.; SirinathsinghjiD. J. S.; ClarkeD. J.; BjörklundA.Striatal grafts in rats with unilateral striatal lesions. III. Recovery from dopamine dependent motor asymmetry and deficits in skilled paw reaching.Neuroscience24: 813–820; 1988.
23.
DunnettS. B.; IversenS.Sensorimotor impairments following localized kainic acid and 6-hydroxydopamine lesions of the neostriatum.Brain Res.248: 121–127; 1982.
24.
EhrlichM.; RosenN.; KuriharaT.; ShalabyI.; GreengardP.DARPP-32 development in the caudate nucleus is independent of afferent input from the substatia nigra.Dev. Brain Res.54: 257–263; 1990.
25.
FolkerthR. D.; DursoR.Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts [see comments].Neurology46: 1219–1225; 1996.
26.
FosterG. A.; SchultzbergM.; HokfeltT.; GoldsteinM.; HemmingsH. C.Jr.; OuimetC. C.; WalaasS. I.; GreengardP.Development of a dopamine- and cyclic adenosine 3′: 5′-monophosphate-regulated phosphoprotein (DARPP-32) in the prenatal rat central nervous system, and its relationship to the arrival of presumptive dopaminergic innervation.J. Neurosci.7: 1994–2018; 1987.
27.
FreemanT. B.; SanbergP. R.; IsacsonO.Development of the human striatum: Implications for fetal striatal transplantation in the treatment of Huntington's disease.Cell Transplant.4: 539–545; 1995.
28.
FrickerR. A.; AnnettL. E.; TorresE. M.; DunnettS. B.The placement of a striatal ibotenic acid lesion affects skilled forelimb use and the direction of drug-induced rotation.Brain Res. Bull.41: 409–416; 1996.
29.
FrickerR. A.; BarkerR. A.; FawcettJ. W.; DunnettS. B.A comparative study of preparation techniques for improving the viability of striatal grafts using vital stains, in vitro cultures and in vivo grafts.Cell Transplant.5: 599–611; 1996.
30.
FrickerR. A.; TorresE. M.; HumeS. P.; MyersR.; Opacka-JufferyJ.; AshworthS.; BrooksD. J.; DunnettS. B.The effect of donor age on the survival and function of embryonic striatal grafts in the adult rat brain II. Correlation between positron emission tomography and reaching behaviour.Neuroscience79: 711–721; 1997.
31.
Grasbon-FrodlE. M.; NakaoN.; LindvallO.; BrundinP.Developmental features of human striatal tissue transplanted in a rat model of Huntington's disease.Neurobiol. Dis.3: 299–311; 1997.
32.
GraybielA. M.; LiuF. C.; DunnettS. B.Intrastriatal grafts derived from fetal striatal primordia. 1. Phenotypy and modular organization.J. Neurosci.9: 3250–3271; 1989.
33.
HantrayeP.; RicheD.; MaziereM.; IsacsonO.A primate model of Huntington's disease: Behavioral and anatomical studies of unilateral excitotoxic lesions of the caudate-putamen in the baboon.Exp. Neurol.108: 91–104; 1990.
34.
HedreenJ. C.; FolsteinS. E.Early loss of neostriatal striosome neurons in Huntington's disease.J. Neuropathol. Exp. Neurol.54: 105–120; 1995.
35.
HedreenJ. C.; PeyserC. E.; FolsteinS. E.; RossC. A.Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease.Neurosci. Lett.133: 257–261; 1991.
36.
IsacsonO.; BrundinP.; KellyP. A. T.; GageF. H.; BjörklundA.Functional neuronal replacement by grafted striatal neurons in the ibotenic acid-lesioned striatum.Nature311: 458–460; 1984.
37.
KendallA. L.; RaymentF.; TorresE. M.; BakerH.; RidleyR.; DunnettS. B.Functional integration of striatal allografts in a primate model of Huntington's disease.Nat. Med.4: 727–729; 1998.
38.
KopyovO. V.; JacquesS.; LiebermanA.; DumaC.; EagleK. S.Safety of intrastriatal neurotransplantation for Huntington's disease patients.Exp. Neurol.149: 97–108; 1998.
39.
KopyovO. V.; JaquesS.; KurthM.; PhilpottL.; LeeA.; PattersonM.; DumaC.; KogosovE.; LiebermanA.; EagleK. S.Neurotransplantation of fetal lateral ganglionic eminence tissue in three patients with Huntington's disease.Soc. Neurosci. Abstr.22: 227; 1996.
Labandeira-GarciaJ. L.; WictorinK.Development and integration of intrastriatal striatal grafts implanted into long-term ibotenate lesions.J. Neural Transplant. Plast.3: 181–182; 1992.
42.
Labandeira-GarciaJ.L.; WictorinK.; CunninghamE. T.; BjörklundA.Development of intrastriatal striatal grafts and their afferent innervation from the host.Neuroscience42: 407–426; 1991.
LehmannJ.; FibigerH.Acetylcholinesterase in the substantia nigra and caudate-putamen of the rat: Properties and localisation of dopaminergic neurons.J. Neurochem.30: 615–624; 1978.
45.
LindvallO.Clinical application of neuronal grafts in Parkinson's disease.J. Neurol.242: S54–S56; 1994.
46.
ListeI.; RozasG.; GuerraM.; Labandeira-GarciaJ. L.Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors.Brain Res.700: 1–12; 1995.
47.
MadrazoI.; Franco-BourlandR. E.; CastrejonH.; CuevasC.; Ostrosky-SolisF.Fetal striatal homotransplantation for Huntington's disease: First two case reports.Neurol. Res.17: 312–315; 1995.
MasonS. T.; FibigerH. C.Kainic acid lesions of the striatum: Behavioural sequalae similar to Huntington's chorea.Brain Res.155: 313–329; 1978.
50.
MayerE.; BrownV.; DunnettS. B.; RobbinsT.Striatal graft-associated recovery of a lesion-induced performance deficit in the rat requires learning to use the transplant.Eur. J. Neurosci.4: 119–126; 1992.
51.
McConnellS.; KaznowskiC.Cell cycle dependence of laminar determination in developing neocortex.Science254: 282–285; 1991.
52.
McGeorgeA.; FaullR.The organization and collateralization of corticostriate neurones in the motor and sensory cortex of the rat brain.Brain Res.423: 318–324; 1987.
53.
MontoyaC.; AstellS.; DunnettS. B.Effects of nigral and striatal grafts on skilled forelimb use in the rat.Prog. Brain Res.82: 459–466; 1990.
54.
MorganJ.; CurranT.Stimulus-transcription coupling in neurons: Role of cellular immediate-early genes.Trends Neurosci.12: 459–462; 1989.
55.
NaimiS.; JenyR.; HantrayeP.; PeschanskiM.; RicheD.Ontogeny of human striatal DARPP-32 neurons in fetuses and following xenografting to the adult rat brain.Exp. Neurol.137: 15–25; 1996.
56.
NakaoN.; BrundinP.; FunaK.; LindvallO.; OdinP.Trophic and protective effect of brain-derived neurotrophic factor on striatal DARPP-32-containing neurons in vitro.Dev. Brain Res.90: 92–101; 1995.
57.
NakaoN.; Grasbon-FrodlE. M.; WidnerH.; BrundinP.DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease.Neuroscience74: 959–970; 1996.
58.
NakaoN.; OdinP.; BrundinP.Selective sub-dissection of the striatal primordium for cultures affects the yield of DARPP-32 containing neurones.Neuroreport5: 1081–1084; 1994.
59.
NakaoN.; OdinP.; LindvallO.; BrundinP.Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-1, and neurotrophin-3 on striatal neurons in culture.Exp. Neurol.138: 144–157; 1996.
60.
NormanA. B.; NorgrenA.; WyattL.; HildebrandJ.; SanbergP. R.The direction of apomorphine induced rotation behavior is dependent on the location of the excitotoxic lesions in the rat basal ganglia.Brain Res.569: 139–147; 1992.
NothiasF.; OntenienteB.; GeffardM.; PeschanskiM.Rapid growth of monoaminergic fibers into fetal cell transplants.Brain Res.463: 341–345; 1988.
63.
OlssonM.; BjörklundA.; CampbellK.Early specification of striatal projection neurons and interneuronal subtypes in the lateral and medial ganglionic eminence.Neuroscience84: 867–876; 1998.
64.
OlssonM.; CampbellK.; WictorinK.; BjörklundA.Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence.Neuroscience69: 1169–1182; 1995.
65.
PakzabanP.; DeaconT. W.; BurnsL. H.; IsacsonO.Increased proportion of acetylcholinesterase-rich zones and improved morphological integration in host striatum of fetal grafts derived from the lateral but not the medial ganglionic eminence.Exp. Brain Res.97: 13–22; 1993.
66.
PalfiS.; CondeF.; RicheD.; BrouilletE.; DautryC.; MittouxV.; ChiboisA.; PeschanskiM.; HantrayeP.Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease.Nat. Med.4: 963–966; 1998.
67.
PalfiS.; NguyenJ. P.; BrugieresP.; Le GuerinelC.; HantrayeP.; RemyP.; RostaingS.; DeferG. L.; CesaroP.; KeravelY.; PeschanskiM.MRI-stereotactical approach for neural grafting in basal ganglia disorders.Exp. Neurol.150: 272–281; 1998.
68.
PeschanskiM.; CesaroP.; HantrayeP.Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease.Neuroscience68: 273–285; 1995.
69.
PeschanskiM.; CesaroP.; HantrayeP.What is needed versus what would be interesting to know before undertaking neural transplantation in patients with Huntington's disease.Neuroscience71: 899–900; 1996.
70.
PhelpsE.; BradyD.; VaughnJ.The generation and differentiation of cholinergic neurons in the rat caudate-putamen.Dev. Brain Res.46: 47–60; 1989.
71.
PisaM.Motor functions of the striatum in the rat: Critical role of the lateral region in tongue and forelimb reaching.Neuroscience24: 453–463; 1988.
72.
PundtL. L.; KondohT.; ConradJ. A.; LowW. C.Transplantation of human striatal tissue into a rodent model of Huntington's disease: Phenotypic expression of transplanted neurons and host-to-graft innervation.Brain Res. Bull.39: 23–32; 1996.
73.
QuinnN.; BrownR.; CraufurdD.; GoldmanS.; HodgesJ.; KieburtzK.; LindvallO.; MacMillanJ.; RoosR.Core Assessment Program for Intracerebral Transplantation in Huntington's Disease (CAPIT-HD).Mov. Disord.11: 143–150; 1996.
74.
ReierP. J.; BregmanB. S.; WujekJ. R.Intraspinal transplantation of embryonic spinal cord tissue in neonatal and adult rats.J. Comp. Neurol.247: 275–296; 1986.
75.
ReinerA.; AlbinR. L.; AndersonK. D.; D'AmatoC. J.; PennyJ. B.; YoungA. B.Differential loss of striatal projection neurons in Huntington's disease.Proc. Natl. Acad. Sci. USA85: 5733–5737; 1988.
76.
RoosR. A. C.; PruytJ. F. M.; deVriesJ.; BotsG.Th. A. M.Neuronal distribution in the putamen in Huntington's disease.J. Neurol. Neurosurg. Psychiatry48: 422–425; 1985.
77.
RutherfordA.; Garcia-MunozM.; DunnettS. B.; ArbuthnottG.Electrophysiological demonstration of host cortical inputs to striatal grafts.Neurosci. Lett.83: 275–281; 1987.
78.
SagarS.; SharpF.; CurranT.Expression of c-fos protein in the brain: Metabolic mapping at the cellular level.Science240: 1328–1330; 1988.
79.
SanbergP. R.; CalderonS. F.; GiordanoM.; TewJ.; M; NormanA. B.The quinolinic acid model of Huntington's disease: Locomotor abnormalities.Exp. Neurol.105: 45–53; 1989.
80.
SanbergP. R.; HenaultM. A.; DeckelA.W.Locomotor hyperactivity: Effects of multiple striatal transplants in an animal model of Huntington's disease.Pharmacol. Biochem. Behav.25: 297–300; 1986.
81.
SchumacherJ. M.; HantrayeP.; BrownellA. L.; RicheD.; MadrasB. K.; DavenportP. D.; MaziereM.; ElmalehD. R.; BrownellG. L.; IsacsonO.A primate model of Huntington's disease: Functional neural transplantation and CT-guided stereotactic procedures.Cell Transplant.1: 313–322; 1992.
82.
ShannonK. M.; KordowerJ. H.Neural transplantation for Huntington's disease: Experimental rational and recommendations for clinical trials.Cell Transplant.5: 339–352; 1996.
83.
SmartI. H. M.; SturrockR. R.Ontogeny of the neostriatum. In: DivacI.; ObergR. G., eds. The neostriatum.Oxford: Pergamon;1979: 127–146.
84.
SmithL.; HohmannC.; EbnerF.The development of specific cell types and connectivity in neocortical transplants. In: BjörklundA.; SteneviU., eds. Neural grafting in the mammalian CNS.Amsterdam: Elsevier;1985: 249–255.
85.
SoteloC.; Alvarado-MallartR.Cerebellar transplants: Immunocytochemical study of the specificity of Purkinje cells' inputs and outputs. In: BjörklundA.; SteneviU., eds. Neural grafting in the mammalian CNS.Amsterdam: Elsevier;1985: 205–215.
86.
StineO. C.; LiS.; PleasantN.; WagsterM. V.; HedreenJ. C.; RossC. A.Expression of the mutant allele of IT-15 (the HD gene) in striatum and cortex of Huntington's disease patients.Hum. Mol. Genet.4: 15–18; 1995.
87.
SundeN.; ZimmerJ.; LaurbergS.Repair of neonatal irradiation-induced damage to the rat fascia dentata. Effects of delayed intracerebral transplantation. In: BjörklundA.; SteneviU., eds. Neural grafting in the mammalian CNS.Amsterdam: Elsevier;1985: 301–308.
88.
The Huntington's Disease Collaborative Research Group.A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.Cell72: 971–983; 1993.
89.
VecseiL.; BealM. F.Comparative behavioral and neurochemical studies with striatal kainic acid or quinolinic acid-lesioned rats.Pharmacol. Biochem. Behav.39: 473–478; 1991.
WattsC.; BrastedP.; DunnettS. B.The morphology, integration and functional efficacy of striatal grafts differs between cell suspensions and tissue pieces.Cell Transplant. (in press).
92.
Watts, C.; Brasted, P.; Eagle, D.; Dunnett, S. B.Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease.Exp. Neurol. (in press).
93.
WattsC.; DunnettS. B.Effects of severity of host striatal damage on the morphological development of intrastriatal transplants in a rodent model of Huntington's disease: Implications for timing of surgical intervention.J. Neurosurg.89: 267–274; 1998.
94.
WattsC.; McNamaraI.; DunnettS. B.There is no relationship between the number of striatal cells implanted and the patch volume of intrastriatal transplants in a rat model of Huntington's disease.Proc. Soc. Neurosci.1: 42.2; 1997.
95.
WattsC.; McNamaraI.; DunnettS. B.Volume and differentiation of striatal grafts in rats: Relationship to the number of cells implanted.Cell Transplant.9: 65–72; 2000.
96.
WattsC.; CaldwellM.; DunnettS. B.The development of intracerebral cell-suspension implants is influenced by the grafting medium.Cell Transplant.7: 573–583; 1998.
97.
WattsC.; DunnettS. B.; RosserA. E.Effect of embryonic donor age and dissection on the DARPP-32 content of cell suspensions used for intrastriatal transplantation.Exp. Neurol.148: 271–280; 1997.
98.
WhishawI. Q.; O'ConnorW. T.; DunnettS. B.The contributions of motor cortex, nigrostriatal dopamine and caudate-putamen to skilled forelimb use in the rat.Brain109: 805–843; 1986.
99.
WictorinK.; BjörklundA.Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum-II.Cortical afferents. Neuroscience30: 297–311; 1989.
100.
WictorinK.; ClarkeD. J.; BolamP. J.; BjörklundA.Fetal striatal neurons grafted into the ibotenate lesioned adult striatum: Efferent projections and synaptic contacts in the host globus pallidus.Neuroscience37: 301–315; 1990.
101.
WictorinK.; IsacsonO.; FischerW.; NothiasF.; PeschanskiM.; BjörklundA.Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum-I.Subcortical afferents. Neuroscience27: 547–562; 1988.
102.
WictorinK.; SimerlyR.; IsacsonO.; SwansonL.; BjörklundA.Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum-III. Efferent projecting graft neurons and their relation to host afferents within the grafts.Neuroscience30: 313–330; 1989.
103.
WictorinK.Anatomy and connectivity of intrastriatal striatal transplants.Prog. Neurobiol.38: 611–639; 1992.
104.
WilsonC. J.; XuZ. C.; EmsonP. C.; FelerC.Anatomical and physiological properties of the cortical and thalamic innervations of neostriatal tissue grafts.Prog. Brain Res.82: 417–426; 1990.
